| EPB0207 | Adverse pregnancy outcomes following dolutegravir transition among women delivering at surveillance sites in Eswatini | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0206 | HIV treatment outcomes after 10 years on ART in the TREAT Asia Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0205 | The relationship between gender-affirming hormone therapy and tenofovir dried blood spot concentrations among transgender adults switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for pre-exposure prophylaxis | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0204 | Incidence of infections across Islatravir clinical development programs | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0203 | Frailty transition among older adults living with HIV in Thailand: a five-year prospective cohort study | E-poster | HIV and ageing |
| EPB0202 | Measuring intrinsic capacity: a screening tool for integrated care in ageing people living with HIV | E-poster | HIV and ageing |
| EPB0201 | Aging of brain network connectivity corresponds to cognitive impairment in persons with HIV | E-poster | HIV and ageing |
| EPB0200 | Lower prevalence of potential drug-drug interactions among people living with HIV in the era of integrase inhibitor-based antiretroviral therapy | E-poster | HIV and ageing |
| EPB0199 | Weight gain and lipid changes with switching from boosted protease inhibitor-based regimens to bictegravir/tenofovir alafenamide/emtricitabine | E-poster | Clinical complications of HIV and antiretroviral therapy |
| EPB0198 | A patient with undiagnosed HIV presenting with hemophagocytic lymphohistiocytosis - the importance of routine HIV testing in hospitalized patients | E-poster | Clinical complications of HIV and antiretroviral therapy |